Kanavos, Panagiotis


Dr Panagiotis Kanavos  

Department

Position held

LSE Health

European Institute

Department of Social Policy

Associate Professor in International Health Policy

Experience keywords:

biotechnology; fiscal policy; industrial economics; health economics; transitional economies; health related high technology industries; pharmaceuticals; economics; international perspective; health technology assessment; health policy

Languages:

French [Spoken: Intermediate, Written: Fluent]; German [Spoken: Intermediate, Written: Fluent]; Greek [Spoken: Fluent, Written: Fluent]; Romanian [Spoken: Basic, Written: Intermediate]; Spanish [Spoken: Basic, Written: Intermediate]

Media experience:

RadioTV

Contact Points

LSE phone number:

+44 (0)20 7955 6802

Publications

LSE Research Online, Funnelback Search

2014

Kanavos, Panos and Wouters, Olivier J. (2014) Competition issues in the distribution of pharmaceuticals

Kanavos, Panos and Wouters, Olivier J. (2014) Concurrence dans la distribution de produits pharmaceutiques

Kanavos, Panos and Wouters, Olivier J. (2014) Pharmaceutical parallel trade: legal, policy, and economic issues In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier, San Diego, USA, 20-28. ISBN 9780123756787

Kanavos, Panos and Angelis, Aris (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online. ISSN 1178-2595

Tordrup, David and Tzouma, Victoria and Kanavos, Panos (2014) Orphan drug considerations in Health Technology Assessment in eight European countries Rare Diseases and Orphan Drugs: An International Journal of Public Health, 1 (3). 86-97.

Vandoros, Sotiris and Kanavos, Panos (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union The World Economy, 37 (6). 856-880. ISSN 0378-5920

Kanavos, Panos (2014) Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States Health Policy, online. 1-13. ISSN 0168-8510

Ferrario, Alessandra and Sautenkova, Nina and Bezverhni, Zinaida and Seicas, Rita and Habicht, Jarno and Kanavos, Panos and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova Journal of Pharmaceutical Policy and Practice, 7 (1). 4. ISSN 2052-3211

Tordrup, David and Mossman, Jean and Kanavos, Panos (2014) Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? International Journal of Technology Assessment in Health Care, 30 (01). 10-19. ISSN 0266-4623

Grimaccia, Federico and Kanavos, Panos (2014) Cost, outcomes, treatment pathways and challenges for diabetes care in Italy Globalization and Health, 10 (58). ISSN 1744-8603

2013

Ferrario, Alessandra and Kanavos, Panos (2013) Managed entry agreements for pharmaceuticals: the European experience EMiNet, Brussels, Belgium.

Ferrario, Alessandra and Kanavos, Panos (2013) The LSE Summit: risk sharing and managed entry agreements Health and Social Care at LSE (20 Nov 2013) Blog entry

Tordrup, David and Ahmed, Waqas and Bukhari, Khalid Saeed and Kanavos, Panos (2013) Availability of medical supplies during the 2010 Pakistan floods Lancet Global Health, 1 (1). e13-e14. ISSN 2214-109X

Jackson, Timothy L. and Nicod, Elena and Angelis, Aris and Grimaccia, Federico and Prevost, Andrew T. and Simpson, Andrew R.H. and Kanavos, Panos (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy Retina, 33 (10). 2012-2017. ISSN 0275-004X

Ferrario, Alessandra and Kanavos, Panos (2013) Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease Health and Social Care at LSE (19 Jun 2013) Blog entry

Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets Applied Economics, 45 (22). 3230-3239. ISSN 0003-6846

Jackson, Timothy and Nicod, Elena and Simpson, Andrew and Angelis, Aris and Grimaccia, Federico and Kanavos, Panos (2013) Symptomatic vitreomacular adhesion Retina, 33 (8). 1503-1511. ISSN 1539-2864

Kanavos, Panos and Angelis, Aris (2013) Multiple criteria decision analysis for value based assessment of new medical technologies: a conceptual framework LSE Health working papers, 33. LSE Health, London, UK.

Kanavos, Panos and Ferrario, Alessandra and Vandoros, Sotiris and Anderson, Gerard F. (2013) Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs Health Affairs, 32 (4). 753-761. ISSN 0278-2715

Jackson, Timothy L. and Nicod, Elena and Angelis, Aris and Grimaccia, Federico and Prevost, Toby and Simpson, Andrew and Kanavos, Panos (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion Retina, 33 (6). 1099-1108. ISSN 1539-2864

Bertoldi, Andréa D. and Kanavos, Panos and França, Giovanny V. A. and Carraro, André and Tejada, Cesar Augusto and Hallal, Pedro C. and Ferrario, Alessandra and Schmidt, Maria (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review Globalization and Health, 9 (1). 62. ISSN 1744-8603

Tordrup, David and Angelis, Aris and Kanavos, Panos (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey Applied Health Economics and Health Policy. 1-14. ISSN 1175-5652

Tordrup, David and Angelis, Aris and Kanavos, Panos (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey (Review) Applied Health Economics and Health Policy, 11 (6). 639-652. ISSN 1175-5652

2012

Kanavos, Panos and van den Aardweg, Stacey and Schurer, Willemien (2012) Diabetes expenditure, burden of disease and management in 5 EU countries The London School of Economics and Political Science, London, UK.

Sautenkova, Nina and Ferrario, Alessandra and Bolokhovets, Ganna and Kanavos, Panos (2012) Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova: final report Health policy paper series, no. 6. World Health Organization, Regional Office for Europe, Copenhagen, Denmark.

Nicod, Elena and Kanavos, Panos (2012) Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions Health Policy, 108 (2-3). 167-177. ISSN 0168-8510

Kanavos, Panos and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward Value in Health, 15 (8). 1182-1184. ISSN 1098-3015

Linertová, Renata and Serrano-Aguilar, Pedro and Posada-de-la-Paz, Manuel and Hens-Pérez, Manuel and Kanavos, Panos and Taruscio, Domenica and Schieppati, Arrigo and Stefanov, Rumen and Péntek, Márta and Delgado, Claudia and Graf von der Schulenburg, Johann-Matthias and Persson, Ulf and Chevreul, Karine and Fattore, Giovanni and Worbes-Cerezo, Melany and Sefton, Mark and López-Bastida, Julio (2012) Delphi approach to select rare diseases for a European representative survey: the BURQOL-RD study Health Policy, 108 (1). 19-26. ISSN 0168-8510

Prinja, Shankar and Aggarwal, Arun Kumar and Kumar, Rajesh and Kanavos, Panos (2012) User charges in health care: evidence of effect on service utilization & equity from north India Indian Journal of Medical Research, Supplement , 136. 868-876. ISSN 0367-9012

Helfer, Ana Paula and Camargo, Aline Lins and Tavares, Noemia Urruth Leão and Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público Revista Panamericana de Salud Pública / Pan American Journal of Public Health, 31 (3). 225-232. ISSN 1020-4989

Prinja, Shankar and Kanavos, Panos and Kumar, Rajesh (2012) Health care inequities in north India: role of public sector in universalizing health care Indian Journal of Medical Research, 136. 421-431. ISSN 0971-5916

2011

Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences Significance, 8 (1). 15-18. ISSN 1740-9705

Kanavos, Panos and Vandoros, Sotiris and Irwin, Rachel and Nicod, Elena and Casson, Margaret (2011) Differences in costs of and access to pharmaceutical products in the EU IP/A/ENVI/ST/2010-12 . European Parliament, Brussels.

Kanavos, Panos and Schurer, Willemien and Vogler, Sabine (2011) The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices European Commission, Brussels, Belgium.

Von der Schulenburg, Fritz and Vandoros, Sotiris and Kanavos, Panos (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors Health Economics Review, 1 (1). 1-8. ISSN 2191-1991

Sorenson, Corinna and Kanavos, Panos (2011) Medical technology procurement in Europe: a cross-country comparison of current practice and policy Health Policy, 100 (1). 43-50. ISSN 0168-8510

Kanavos, Panos G. and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries Health Economics, Policy and Law, 6 (3). 1-31. ISSN 1744-1331

2010

Kanavos, Panos and Nicod, Elena and Espin, Jaime and van den Aardweg, Stacey (2010) Short- and long-term effects of value-based pricing vs. external price referencing EMiNet.

Kanavos, Panos and Nicod, Elena and van den Aardweg, Stacey and Pomedli, Stephen (2010) The impact of health technology assessments: an international comparison Euro Observer, 12 (4). 1-7. ISSN 1020-7481

Kanavos, Panos and Schurer, Willemien (2010) The burden of colorectal cancer: prevention, treatment and quality of services The European Journal of Health Economics, 10 (Supp.1). 1-3. ISSN 1618-7598

Kanavos, Panos and Sullivan, R. and Lewison, G. and Schurer, W. and Eckhouse, S. and Vlachopioti, Z. (2010) The role of funding and policies on innovation in cancer drug development Ecancermedicalscience, 4. ISSN 1754-6605

Kanavos, Panos and Vandoros, Sotiris and Irwin, Rachel and Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future European Parliament, Brussels, Belgium.

Kanavos, Panos and Vandoros, Sotiris (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and Decision Economics, 31 (5). 325-338. ISSN 0143-6570

Schurer, Willemien and Kanavos, Panos (2010) Colorectal cancer management in the United Kingdom: current practice and challenges The European Journal of Health Economics, 10 (Supp.1). 85-90. ISSN 1618-7598

Kanavos, Panos and Gemmill-Toyama, Marin (2010) Prescription drug coverage among elderly and disabled Americans: can Medicare—Part D reduce inequities in access? International Journal of Health Care Finance and Economics, 10 (3). 203-218. ISSN 1389-6563

Lluch, Maria and Kanavos, Panos (2010) Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy, 95 (2-3). 245-254. ISSN 0168-8510

Geitona, Mary and Kanavos, Panos (2010) Colocteral cancer management and prevention policies in Greece The European Journal of Health Economics, 10 (Supp.1). 27-33. ISSN 1618-7598

Kanavos, Panos and Schurer, Willemien (2010) The dynamics of colorectal cancer management in 17 countries The European Journal of Health Economics, 10 (Supp.1). 115-129. ISSN 1618-7598

2009

Sorenson, Corinna and Kanavos, Panos (2009) Topic 1: financing medical devices in France and the UK European Health Technology Institute on Socio-Economic Research.

Kanavos, Panos and Seeley, Elizabeth and Vandoros, Sotiris (2009) Tender systems for outpatient pharmaceuticals in the European Union: evidence from the Netherlands, Germany and Belgium Enterprise and Industry, European Commission, Brussels, Belgium.

Sorenson, Corinna and Kanavos, Panos and Karamalis, M. (2009) HTA in Central and Eastern Europe: current status, challenges and opportunities Journal of Medical Device Regulation, 6 (1). 34-45. ISSN 1759-149X

Kanavos, Panos and Vandoros, Sotiris and Habicht, Jarno and de Joncheere, Kees (2009) Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy Regional Office for Europe, World Health Organization, Copenhagen, Denmark.

Kanavos, Panos and Vandoros, Sotiris and Garcia-Gonzalez, Pat (2009) Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP Globalization and Health, 5 (19). 1-13. ISSN 1744-8603

2008

Kanavos, Panos and Vandoros, Sotiris (2008) Validation of the Russian federal prescribing database and evaluation of policy outcomes Russian Federal Bureau of Obligatory Medical Insurance.

Sorenson, Corinna and Drummond, Michael and Kanavos, Panos and McGuire, Alistair (2008) National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? National Pharmaceutical Council, Virginia, USA.

Kanavos, Panos and Schurer, Willemien and Owusu-Apenten, Candida and Sullivan, Richard (2008) Colorectal cancer in Europe and Australia: challenges and opportunities for the future 9780853283027. LSE Health, London School of Economics and Political Science, London, UK. ISBN 9780853283027

Sorenson, Corinna and Drummond, Michael and Kanavos, Panos (2008) Ensuring value for money in health care: the role of health technology assessment in the European Union Observatory studies series, 11. World Health Organization Regional Office for Europe, Copenhagen, Denmark. ISBN 9789289071833

McGuire, Alistair and Raikou, Maria and Kanavos, Panos (2008) Pricing pharmaceuticals: value based pricing in what sense? Eurohealth, 14 (2). 3-6. ISSN 1356-1030

Sorenson, Corinna and Drummond, Michael and Kanavos, Panos and McGuire, Alistair (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? Ispor Connections, 14 (4). 7-9. ISSN 1538-5108

Kanavos, Panos and Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence Economic Policy, 23 (55). 499-544. ISSN 0266-4658

2007

Costa-i-Font, Joan and Kanavos, Panos (2007) Importaciones paralelas de medicamentos: El caso de la Simvastaina en Alemania, Holanda y el Reino Unido Gaceta Sanitaria, 21 (1). 53-59. ISSN 0213-9111

Costa-i-Font, Joan and Kanavos, Panos and Rovira-Forns, Joan (2007) Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia Applied Economics, 39 (5). 541-551. ISSN 0003-6846

Kanavos, Panos (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, vol. 23(1). Current Medical Research and Opinion, 23 (1). 105-116. ISSN 0300-7995

Sorenson, Corinna and Drummond, Michael and Kanavos, Panos (2007) Ensuring value for money in health care: The role of HTA in the European Union

Kanavos, Panos and Costa-i-Font, Joan and McGuire, Alistair (2007) Product differentiation, competition and regulation of new drugs: the case of statins in four European countries Managerial and Decision Economics, 28 (4-5). 455-465. ISSN 1099-1468

Costa-i-Font, Joan and Kanavos, Panos (2007) Medicines in parallel trade in the European Union: a gravity specification LSE Health working papers, 6/2007. London School of Economics and Political Science, London, UK.

2006

Kanavos, Panos and Saka, R (2006) Economic evaluation for orphan drugs: is it possible? Eurohealth. ISSN 1356-1030

Kanavos, Panos (2006) The rising burden of cancer in the developing world Annals of Oncology, 17 (Supple). ISSN 0923-7534

Tatar, Mehtap and Kanavos, Panos (2006) Health care reform in Turkey: a dynamic path in the wake of political consensus Eurohealth, 12 (1). 20-22. ISSN 1356-1030

Hockley, Tony and Kanavos, Panos and Rudisill, Caroline (2006) The IFPMA Health Partnerships Survey: a critical appraisal London School of Economics and Political Science, London, UK.

Morgan, S and McMahon, M and Mitton, C and Rougehead, E and Kirk, R and Kanavos, Panos and Menom, D (2006) Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom Health Affairs, 25 (2). 337-347. ISSN 0278-2715

Kanavos, Panos and Ustel, I. and Tatar, M. and Costa-i-Font, Joan (2006) Health and drug sector reform in Turkey: caveats and opportunities Health and Social Care, London School of Economics and Political Science, London, UK.

Gemmill, Marin and Costa-i-Font, Joan and Kanavos, Panos (2006) Insurance coverage and the heterogeneity of health and drug spending in the United States Geneva Papers on Risk and Insurance, 31 (4). 669-691. ISSN 1018-5895

Kanavos, Panos and Yfantopoulos, J. and Politis, C. and Vandoros, C. (2006) The economics of blood: gift of life or a commodity? International Journal of Technology Assessment in Health Care, 22 (3). 338-343. ISSN 0266-4623

2005

Kanavos, Panos and Holmes, P and Loudon, David and Benedict, Irvine (2005) Pharmaceutical parallel trade in the UK CIVITAS, London, UK. ISBN 9781903386392

Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe Scrip reports. Scrip, London.

Kanavos, Panos and Gross, David and Taylor, David (2005) Parallel trading in medicines: Europe’s experience and its implications for commercial drug importation in the United States 2005-07. American Association for Retired Persons, Washington, DC., USA.

Kanavos, Panos and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS Disease Management and Health Outcomes, 13 (6). 359-370. ISSN 1173-8790

Kanavos, Panos and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS Disease Management and Health Outcomes, 13 (6). 359-370. ISSN 1173-8790

Knapp, Martin and Kanavos, Panos and King, Derek and Yesudian, Hannah Monica (2005) Economic issues in access to medications: Schizophrenia treatment in England International Journal of Law and Psychiatry, 28 (5). 514-531. ISSN 0160-2527

Costa-i-Font, Joan and Kanavos, Panos (2005) Efectos del comercio paralelo de medicamentos en la Unión Europea y evidencia de Alemania Boletin de Estudios Economicos, 60 (185). 251-263. ISSN 0006-6249

Park, Sylvia and Ross-Degnan, Dennis and Adams, Alyce S and Sabin, James and Kanavos, Panagiotis and Soumerai, Stephen B (2005) Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: a population-based study British Journal of Psychiatry, 187 (2). 137-142. ISSN 0007-1250

Kanavos, Panos and Costa-i-Font, Joan (2005) Pharmaceutical parallel trade in Europe: stakeholders and competition effects Economic Policy, 20 (44). 751-798. ISSN 0266-4658

2004

Kanavos, Panos and Holmes, P. R. (2004) Financial flows to global health partnerships Department for International Development, London, UK.

Kanavos, Panagiotis and Tatar, D and Taylor, D (2004) Regulating pharmaceutical distribution and retail pharmacy in Europe In: Mossialos, Elias and Mrazek, M and Walley, T, (eds.) Regulating Pharmaceuticals in Europe : Striving for Efficiency, Equity and Quality. Open University Press, Maidenhead, UK, 196-212. ISBN 0335214657

Kanavos, Panos and Costa-i-Font, Joan and Merkur, S. and Gemmill, M. (2004) The economic impact of pharmaceutical parallel trade in European union member states: a stakeholder analysis Special Research Paper, London School of Economics and Political Science, London, UK. ISBN 0753017261

Kanavos, Panos and Soumerai, Stephen B and Ross-Degnan, Dennis (2004) Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector In: Mossialos, Elias and Mrazek, Monique F. and Walley, Tom, (eds.) Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Open University Press on behalf of the European Observatory on Health Systems and Policies, Maidenhead, UK, 97-113. ISBN 9780335214655

Kanavos, Panos and Gemmill, M (2004) Senior citizens and the burden of prescription drug outlays: what lessons for the Medicare prescription drug benefit? Applied Health Economics and Health Policy, 3 (4). 217-227. ISSN 1175-5652

2003

Kanavos, Panos (2003) Implications of financing systems In: Zollner, H and Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Organization for Europe, 69-86.

Kanavos, Panos (2003) Reference pricing for drugs: is it compatible with US healthcare? Health Affairs, 22 (3). 16-30. ISSN 0278-2715

Kanavos, Panos and Mossialos, Elias (2003) Managing healthcare reform: evaluation of available options In: Stoddart, G and Zollner, H and Selby-Smith, C, (eds.) Learning to Live With Healthcare Reform. World Health Organization Regional Office for Europe, Copenhagan, Denmark.

2002

Kanavos, Panos (2002) EU pharmaceutical policy: the challenges and opportunities of enlargement Eurohealth, 8 (4). 24-26. ISSN 1356-1030

Kanavos, Panos and Lim, J Y and Pascual, C S (2002) On improving the poor's access to affordable drugs The World Bank.

Kanavos, Panos and Lim, J Y and Pascual, C S (2002) On improving accessibility of drugs for the poor Philippines health policy note, The World Bank.

Kanavos, Panos (2002) Pharmaceutical regulation in Europe

Kanavos, Panos and Mossialos, Elias (2002) Evaluation of health care reform options In: Zollner, H and Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Economics for Europe, 37-48.

King, Derek R. and Kanavos, Panos (2002) Encouraging the use of generic medicines: implications for transition economies Croatian Medical Journal, 43 (4). 462-469. ISSN 0353-9504

2001

Kanavos, Panos (2001) Overview of pharmaceutical pricing and reimbursement regulation LSE Health, London, U.K..

2000

Kanavos, Panos (2000) The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings Pharmacoeconomics, 18 (6). 523-532. ISSN 1170-7690

Kanavos, Panos and Trueman, P and Bosilevac, A (2000) Can economic evaluation guidelines improve efficiency in resource allocation? International Journal of Technology Assessment in Health Care, 16 (4). 1179-1192. ISSN 0266-4623

Maynard, Alan and Kanavos, Panos (2000) Health economics: an evolving paradigm Health Economics, 9 (3). 183-190. ISSN 1057-9230

Kanavos, Panos and McKee, Martin (2000) Cross-border issues in the provision of health services: are we moving towards a European health policy? Journal of Health Services Research and Policy, 5 (4). 231-236. ISSN 1355-8196

Trueman, P. and Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 1: guidelines for economic evaluation and their role in health policy Clinical Research Focus, 11 (1). 23-29. ISSN 0968-0594

Trueman, P. and Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 2: 'the fourth hurdle': what does it mean for drug development? Clinical Research Focus, 11 (2). 24-29. ISSN 0968-0594

Kanavos, Panos (2000) Towards evidence-based decisions in health care: a prospective assessment of training needs in health economics and management in the European Union Hepac (Health Economics in Prevention and Care), 1 (1). 78-90. ISSN 1439-3972

1999

Kanavos, Panos and Mossialos, Elias (1999) Outstanding regulatory issues in the European Union pharmaceutical market Pharmacoeconomics, 15 (6). 519-533. ISSN 1170-7690

Kanavos, Panos (1999) Financing pharmaceuticals in transition Croatian Medical Journal, 40 (June). 244-259. ISSN 0353-9504


Expert Image

Personal website

 

Browse the Experts Directory:

LSE Research Online|

Collection of LSE research outputs

LSE Consulting|

Service providing unique access
to LSE's expertise

Create or update your
online profile
|

[access restricted to staff]

Research highlights|

Short articles about LSE research